Clinical Trial Update: A Phase 2 Study of HW091077 in Participants With Refractory Chronic Cough Or Unexplained Chronic Cough (RCC/UCC). [Phase 2]

View source ↗

Summary

This update announces a Phase 2 trial of HW091077 for chronic cough that is refractory to standard treatments, which is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• HW091077

Snippet

Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | Conditions: Refractory Chronic Cough | Phase 2 | Status: NOT_YET_RECRUITING